Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
35 participants
INTERVENTIONAL
2018-01-29
2018-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The hypothesis of this study is honey and povidone-iodine could be a good substitute (or equal to) to paraffin gauze on acute laceration wounds.
Honey is chosen because of its versatility and already well-known to be used as a chronic wound dressing. Povidone-iodine was chosen as another alternative because it is still one of the most used substance in rural area as a wound dressing, but there is not enough study to support the usage of this substance. Paraffin gauze was chosen as a representative of modern wound dressing because it fulfilled the standard of wound dressing on acute wound, which is non-adherent and also moist.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Honey Dressing - A Preventive Procedure for Post-Surgical Site Infection.
NCT06220344
Manuka Honey for Wound Care
NCT02259491
Resin Salve Versus Honey Treatment in Wound Care
NCT01868412
Trial of Different Wound Dressings in Split-skin Grafted Third Degree Burns
NCT03674151
MEDIHONEY® Gel Versus Collagenase for Wound Debridement
NCT02482948
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The data of each of the participant was registered on a form which was pre-made by the investigators. It recorded the identity of the patient, history taking, physical examination, and also to record more detailed information about our intervention, such as the amount of stitches and how many and what kind of resources that have been spent on the participant.
Every sample will be categorized into 3 randomized groups of intervention; honey, povidone-iodine, and paraffin gauze, which will also be categorized by location of their wound; face and neck, upper extremity, and lower extremity. Participants on each intervention group are distributed evenly using stratified block randomization. Photos of the wound will be taken before and after the wound is cleaned, and after the wound has been sutured. Every patient will be asked to attend a predetermined schedule for wound care assessment. The wound will be evaluated by photos before and after the wound is cleaned, debrided, or have its sutures removed. Parameter of evaluation will be duration of wound healing per anatomical region, infection, cleanliness of wound, odor, exudate level, pain, itch, and total cost of wound care.
Every paper consists of participants' data that were collected on colored maps based on the intervention group (red: povidone-iodine, yellow: honey, blue: paraffin). At the end of the study, three of the team's members converted the data to be analyzed using Microsoft Excel and SPSS.
The investigators prepared beforehand the Standard Operational Procedures regarding any possibilities of adverse events, such as lidocaine toxicity and honey hypersensitivity and were already approved by the hospital's committee.
The investigators determined the target of the sample size with the total sample of 36 participants, distributed evenly based on intervention groups and wounds' location using stratified block randomization
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Honey
0.05 cc of honey (Madu Nusantara®) per 1 cm of laceration, given every predetermined wound care schedule
Honey
Substance is given topically after the wound has been sutured
Povidone-iodine
0.05 cc of povidone-iodine per 1 cm of laceration, given every predetermined wound care schedule
Povidone-iodine
Substance is given topically after the wound has been sutured
Paraffin gauze
1 layer of paraffin gauze, given every predetermined wound care schedule
Paraffin gauze
Substance is given topically after the wound has been sutured
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Honey
Substance is given topically after the wound has been sutured
Povidone-iodine
Substance is given topically after the wound has been sutured
Paraffin gauze
Substance is given topically after the wound has been sutured
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* An acute open traumatic wound
* Agrees to a voluntary agreement for informed consent
* To be treated in an outpatient setting
Exclusion Criteria
* Patient under the age of 10 and over 60 years old
* Systemic conditions (diabetes mellitus, hypertension, liver' kidney disease)
* Signs of infection
* Consuming steroids and / or antibiotics
* History of keloid
* History of drug and / or alcohol abuse
* Under treatment for chemotherapy or immunocompromised
* Pregnant
* History of allergy towards amoxicillin and / or ibuprofen
Wound factor:
* Acute Open Traumatic Wound that has occured after than 12 hours of admittance to the emergency department
* Open fracture
* Suspicion of contamination from the mechanism of attaining the wound (human or animal bite, body fluids such as faeces, saliva, urine, sperm, or vaginal secretion)
* Penetration trauma (stab wound, gunshot wound, or a joint-affected wound)
* Signs of wound infection
* More than one wound in the same anatomical region
* Possess a chronic wound caused by underlying disease other than trauma
* Wound with exposed tendon and/ or bone
* Wound length dimension no less than 1 cm and no more than 10 cm.
* Hypersensitivity to honey
* Does not attend to scheduled wound care assesment control
* Sample's wish to not be involved anymore with the research at any phase
10 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
S.K. Lerik General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kevin Leonard Suryadinata
Kevin Leonard Suryadinata, MD. Principal Investigator and General Practitioner of S.K. Lerik General Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kevin L Suryadinata, MD
Role: PRINCIPAL_INVESTIGATOR
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
S.K. Lerik General Hospital
Kupang, East Nusa Tenggara, Indonesia
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Fife CE, Carter MJ. Wound Care Outcomes and Associated Cost Among Patients Treated in US Outpatient Wound Centers: Data From the US Wound Registry. Wounds. 2012 Jan;24(1):10-7.
Sood A, Granick MS, Tomaselli NL. Wound Dressings and Comparative Effectiveness Data. Adv Wound Care (New Rochelle). 2014 Aug 1;3(8):511-529. doi: 10.1089/wound.2012.0401.
Dhivya S, Padma VV, Santhini E. Wound dressings - a review. Biomedicine (Taipei). 2015 Dec;5(4):22. doi: 10.7603/s40681-015-0022-9. Epub 2015 Nov 28.
Indonesia | Data. Indonesia [Internet]. 2017 [updated 2017; cited 2017 Jun 18]. Available from: http://data.worldbank.org/country/indonesia.
Trihono. Riset Kesehatan Dasar: Riskesdas 2013. Jakarta: Badan Penelitian dan Pengembangan Kesehatan Kementerian Kesehatan RI.
Produk Domestik Bruto - Analisis PDB Per Kapita Indonesia | Indonesia Investments. Produk Domestik Bruto Indonesia [Internet]. 2017 [updated 2017 Feb 6; cited 2017 Jun 18]. Available from: https://www.indonesia-investments.com/id/keuangan/angka-ekonomi-makro/produk-domestik-bruto-indonesia/item253.
Badan Pusat Statistik. Upah Minimum Regional/Provinsi (UMR/UMP) dan rata-rata Nasional per tahun (Dalam Rupiah), 1997-2016 [Internet]. Jakarta: Badan Pusat Statistik; 2016 [updated 2016; cited 2017 Jun 18]. Available from: https://www.bps.go.id/linkTableDinamis/view/id/917
Moeloek NF. Peraturan Menteri Kesehatan Republik Indonesia Nomor 4 Tahun 2017 Tentang Perubahan Kedua Atas Peraturan Menteri Kesehatan Nomor 52 Tahun 2016 Tentang Standar Tarif Pelayanan Kesehatan Dalam Penyelenggaraan Program Jaminan Kesehatan. Jakarta: Menteri Kesehatan Republik Indonesia; 2017. pg. 6.
Hemani ML, Lepor H. Skin preparation for the prevention of surgical site infection: which agent is best? Rev Urol. 2009 Fall;11(4):190-5.
Angel DE, Morey P, Storer JG, Mwipatayi BP. The great debate over iodine in wound care continues: a review of the literature. Wound Pract Res. 2008;16(1):6-21.
Jull AB, Walker N, Deshpande S. Honey as a topical treatment for wounds. Cochrane Database Syst Rev. 2013 Feb 28;(2):CD005083. doi: 10.1002/14651858.CD005083.pub3.
Saikaly SK, Khachemoune A. Honey and Wound Healing: An Update. Am J Clin Dermatol. 2017 Apr;18(2):237-251. doi: 10.1007/s40257-016-0247-8.
Nevas M, Lindstrom M, Horman A, Keto-Timonen R, Korkeala H. Contamination routes of Clostridium botulinum in the honey production environment. Environ Microbiol. 2006 Jun;8(6):1085-94. doi: 10.1111/j.1462-2920.2006.001000.x.
Shukrimi A, Sulaiman AR, Halim AY, Azril A. A comparative study between honey and povidone iodine as dressing solution for Wagner type II diabetic foot ulcers. Med J Malaysia. 2008 Mar;63(1):44-6.
Gulati S, Qureshi A, Srivastava A, Kataria K, Kumar P, Ji AB. A Prospective Randomized Study to Compare the Effectiveness of Honey Dressing vs. Povidone Iodine Dressing in Chronic Wound Healing. Indian J Surg. 2014 Jun;76(3):193-8. doi: 10.1007/s12262-012-0682-6. Epub 2012 Jul 12.
Li J, Chen J, Kirsner R. Pathophysiology of acute wound healing. Clin Dermatol. 2007 Jan-Feb;25(1):9-18. doi: 10.1016/j.clindermatol.2006.09.007.
Thorne CHM, Gurtner GC, Chung K, Gosain A Mehrara B, Rubin P, Spear SL Grabb and Smith's Plastic Surgery. 7th ed.. Lippincott Williams & Wilkins, Philadelphia, USA. Pg. 14-17.
Siddiqui AR, Bernstein JM. Chronic wound infection: facts and controversies. Clin Dermatol. 2010 Sep-Oct;28(5):519-26. doi: 10.1016/j.clindermatol.2010.03.009.
Kumar V, Cotran RS, Robbin ST. Robbins basic Pathology. 7th ed. Philadelphia, 2003, Saunders.
Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med. 1999 Sep 2;341(10):738-46. doi: 10.1056/NEJM199909023411006. No abstract available.
Troxler M, Vowden K, Vowden P. 2006. Integrating Adjunctive Therapy into Practice: The Importance of Recofnising 'Hard-to-Heal' Wounds.
Lazarus GS, Cooper DM, Knighton DR, Percoraro RE, Rodeheaver G, Robson MC. Definitions and guidelines for assessment of wounds and evaluation of healing. Wound Repair Regen. 1994 Jul;2(3):165-70. doi: 10.1046/j.1524-475X.1994.20305.x.
Fonseca JA et al. Medscape Education. Burn Wound Infections. [Online]. Updated May 25, 2016. Available at http://emedicine.medscape.com/article/213595-overview. Accessed June 16, 2017.
Nicks BA, Ayello EA, Woo K, Nitzki-George D, Sibbald RG. Acute wound management: revisiting the approach to assessment, irrigation, and closure considerations. Int J Emerg Med. 2010 Aug 27;3(4):399-407. doi: 10.1007/s12245-010-0217-5.
Yaghoobi R, Kazerouni A, Kazerouni O. Evidence for Clinical Use of Honey in Wound Healing as an Anti-bacterial, Anti-inflammatory Anti-oxidant and Anti-viral Agent: A Review. Jundishapur J Nat Pharm Prod. 2013 Aug;8(3):100-4. doi: 10.17795/jjnpp-9487. Epub 2013 Jul 17.
Kaufman T, Eichenlaub EH, Angel MF, Levin M, Futrell JW. Topical acidification promotes healing of experimental deep partial thickness skin burns: a randomized double-blind preliminary study. Burns Incl Therm Inj. 1985 Dec;12(2):84-90. doi: 10.1016/0305-4179(85)90032-4.
Greener B, Hughes AA, Bannister NP, Douglass J. Proteases and pH in chronic wounds. J Wound Care. 2005 Feb;14(2):59-61. doi: 10.12968/jowc.2005.14.2.26739. No abstract available.
Biswas A, Bharara M, Hurst C, Gruessner R, Armstrong D, Rilo H. Use of sugar on the healing of diabetic ulcers: a review. J Diabetes Sci Technol. 2010 Sep 1;4(5):1139-45. doi: 10.1177/193229681000400512.
Molan P, Rhodes T. Honey: A Biologic Wound Dressing. Wounds. 2015 Jun;27(6):141-51.
Portenoy RK, Tanner RM. Pain Management: Theory and Practice. Oxford: Oxford University Press; 1996.
Bijur PE, Latimer CT, Gallagher EJ. Validation of a verbally administered numerical rating scale of acute pain for use in the emergency department. Acad Emerg Med. 2003 Apr;10(4):390-2. doi: 10.1111/j.1553-2712.2003.tb01355.x.
Williamson A, Hoggart B. Pain: a review of three commonly used pain rating scales. J Clin Nurs. 2005 Aug;14(7):798-804. doi: 10.1111/j.1365-2702.2005.01121.x.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SKL001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.